Zhejiang Sunflower Health Technology Co., Ltd. Independent Director's 2025 Annual Performance Report
To all shareholders and shareholder representatives:
As an independent director of Zhejiang Sunflower Health Technology Co., Ltd. (hereinafter referred to as the "Company"), I have strictly performed my duties in accordance with the "Company Law," "Securities Law," "Administrative Measures for Independent Directors of Listed Companies," "Shenzhen Stock Exchange Listed Company Self-Regulatory Management Guide No. 2 - Norms for Listed Companies on the ChiNext Market," "Articles of Association," "Independent Director Work System," and other relevant laws, regulations, and regulatory documents during my term of office. I have fully exercised my independent role as an independent director, safeguarding the legitimate interests of all shareholders, especially small and medium shareholders. The report on my performance in 2025 is as follows:
I. Basic Information of Independent Director
My name is Sun Dongzhe. I was born in 1978, am a Chinese national, and hold a doctoral degree. I obtained a Ph.D. in Education from East China Normal University and a Master of Laws and Postdoctoral Degree in Law from East China University of Political Science and Law. I am a member of the Communist Party of China. Since July 2004, I have been employed by East China University of Political Science and Law. Since December 2009, I have served as a part-time lawyer. Since November 2021, I have served as an independent director of Shanghai Tianji Technology Co., Ltd. Since September 11, 2023, I have served as an independent director of this Company. In 2025, my position meets the independence requirements stipulated in the "Administrative Measures for Independent Directors of Listed Companies," and there are no circumstances that affect my independence.
II. Performance of Duties by Independent Director in 2025
(I) Attendance at Board and Shareholder Meetings
In 2025, the Company convened 8 board meetings and 3 shareholder meetings. I personally attended all of them either in person or via communication, and did not entrust others to attend or miss two consecutive meetings. Before the meetings, I carefully read the meeting materials and made necessary inquiries regarding the relevant proposals. During the meetings, I actively participated in discussions, expressed independent opinions objectively and fairly, and exercised my voting rights with a rigorous attitude. I voted in favor of all proposals at the board meetings and did not raise any objections to any matters of the Company. I believe that the convening and holding of the Company's board and shareholder meetings complied with legal procedures, and that major matters underwent the relevant approval procedures, are legal and effective, and do not harm the interests of the Company and all shareholders.
(II) Attendance at Board Special Committees and Independent Director Special Meetings
The Company's board of directors has established four special committees: Strategy, Nomination, Remuneration and Appraisal, and Audit. In 2025, I served as the Chairman of the Remuneration and Appraisal Committee, a member of the Audit Committee, and a member of the Nomination Committee and the Strategy Committee. I actively participated in the daily work of each special committee in accordance with the requirements of their respective work rules, diligently performed my duties, and actively attended meetings, without entrusting others to attend or being absent.
In 2025, I chaired 2 meetings of the Remuneration and Appraisal Committee and reviewed the remuneration and plans for directors and senior management, diligently fulfilling the responsibilities and obligations of the Chairman of the Remuneration and Appraisal Committee.